BioSpace News Archive

Medigate has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2019.

HeartFlow, Inc., a medical technology company uniquely positioned at the intersection of advanced artificial intelligence (AI) capabilities and healthcare, today announced it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2019.

Recursion, a clinical-stage biotechnology company that combines artificial intelligence, experimental biology, and automation to discover and develop drugs at scale, has been named to Fast Company’s annual list of the World’s Most Innovative Companies for 2019.

Nordic Nanovector ASA announces that it will report its fourth quarter and full year 2018 results on Wednesday, 27 February 2019.

Berkeley Lights, Inc., a leader in digital cell biology, announced that it has been named one of Fast Company’s 2019 Most Innovative Companies in Biotech.

Quest Diagnostics and Houston Healthcare are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through a new partnership agreement under which Quest will provide full laboratory management services for Houston Medical Center and Perry Hospital.

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supplemental Biologics License Application (sBLA) for KEYTRUDA

Overall response rate exceeded specified study midpoint target (n=25); company elects to discontinue further patient enrollment as allowed by protocol

Xencor, Inc. announced that the U.S. Food and Drug Administration has placed a partial clinical hold on its Phase 1 study of XmAb14045, a CD123 x CD3 bispecific antibody molecule being evaluated in patients with relapsed or refractory acute myeloid leukemia and other CD123-expressing hematologic malignancies.

CVS Health Corporation announced operating results for the three months and year ended December 31, 2018.